24Oct/13

Children's Mercy gets $5M to continue study of chronic kidney disease – Kansas City Business Journal

Children’s Mercy gets $5M to continue study of chronic kidney disease
Kansas City Business Journal
Children’s Mercy Hospitals and Clinics announced Thursday it received another $5 million to invest in its study of chronic kidney disease, bringing the total amount of funding for the study to $14.2 million. More than 880 children are currently
ASN Emphasizes Need for Early Detection of Kidney DiseaseRenal Business Today
Children’s Mercy announces NIH funding $5 million extension for CKiD, largest Sacramento Bee

all 4 news articles »

24Oct/13

PharmaPoint: Chronic Heart Failure – United Kingdom Drug Forecast and Market … – PR Web (press release)

PharmaPoint: Chronic Heart Failure – United Kingdom Drug Forecast and Market
PR Web (press release)
GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure – United Kingdom Drug Forecast and Market Analysis to 2022”. The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, 

and more »

23Oct/13

Chronic kidney disease hits rural and remote Australians harder – Transforming The Nation's Healthcare

Chronic kidney disease hits rural and remote Australians harder
Transforming The Nation’s Healthcare
AIHW spokesperson, Lisa McGlynn said while the report, Chronic kidney disease: regional variation in Australia revealed a complex overall pattern of kidney disease related deaths and hospitalisations nationally, broad conclusions could be drawn. “We

23Oct/13

Remote monitoring reduced death in advanced heart failure – Family Practice News Digital Network

Remote monitoring reduced death in advanced heart failure
Family Practice News Digital Network
AMSTERDAM – An implant-based remote monitoring system in patients with advanced heart failure significantly reduced the worsening of their condition, overnight hospitalization, and total mortality, according to a trial conducted by the device-maker.

and more »